Singapore, March 10 -- At the APAC Biomanufacturing Leadership Summit 2026 presented by Charles River, Zelle Biotechnology Managing Director Anurag Tulsyan highlights the critical role of analytical science in ensuring quality, regulatory confidence, and efficient biologics development.

Biologics development has entered a new phase of scientific and regulatory complexity, where the ability to understand and control molecular characteristics determines the success of a therapeutic programme. Speaking at the APAC Biomanufacturing Leadership Summit 2026 presented by Charles River, Anurag Tulsyan, Managing Director of Zelle Biotechnology, emphasised that analytical characterisation has become the backbone of modern biologics development.

In...